Table 2.
Studies |
---|
Anemia |
CBC with differential |
Reticulocyte count |
EPO levels |
Coombs test |
Nutritional deficiencies |
Hb electrophoresis and peripheral blood smear examination |
Diamond-Blackfan anemia |
Erythrocyte ADA (before transfusion of red cells) |
Genetic testing |
LGL |
Flow cytometry (as part of a low-grade lymphoma panel) |
TCR rearrangement |
STAT3 gene mutations (eg, in order of frequency Y640F, D661Y, D661V, N647I) |
Autoimmunity and immunologic conditions |
Antinuclear antibodies |
Rheumatoid arthritis antibodies |
Extractable nuclear antigen panel |
Lymphocyte subsets (flow cytometry) |
B-cell dyscrasias studies |
Serum electrophoresis |
Serum immunofixation |
Free light chains |
Immunoglobulins levels |
Bone marrow |
Morphology (myeloid:erythroid ratio, dysplastic changes, giant pronormoblasts) |
Flow cytometry for LGL |
Cytogenetics |
TCR rearrangement |
Virological |
B19 parvovirus |
Viral hepatitis |
HIV |
EBV |
CMV |
Anamnestic data about drug history |
Thymoma studies* |
CT scan of the chest |
Particulary in case of history of myasthenia gravis.
ADA, adenosine deaminase; EBV: Epstein-Barr virus; EPO, erythropoietin; STAT3, signal transducer and activator of transcription 3.